Summary
Burak Günhan is a Senior Principal Biostatistician based in Darmstadt with nine years of experience designing and analyzing early oncology trials using Bayesian methods. He holds a PhD in Biostatistics from the University of Göttingen and has led innovative dose-escalation and dose-schedule optimization studies, serving as trial-lead and core safety committee member. At Merck he blends a drug-developer mindset with hands-on statistical programming, contributing to crmPack and developing R packages that implement meta-analysis and shrinkage methods. His background spans academic methodological research, PK/PD modeling, and industry roles at Novartis, Roche, and Galapagos, reflecting a strong bridge between theory and practice. Notably, he has translated novel Bayesian designs into production-ready Stan and R implementations used across teams and collaborations.
9 years of coding experience
5 years of employment as a software developer
Bachelor of Science (BSc) Mathematics, Bachelor of Science (BSc) Mathematics at Boğaziçi University
Master of Science (MSc) Biostatistics, Master of Science (MSc) Biostatistics at University of Zurich
Doctor of Philosophy (PhD) Biostatistics, Doctor of Philosophy (PhD) Biostatistics at The University of Göttingen
English, German, Turkish